Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Australia Steps Up Priority Review And Faster Assessment Plans

Executive Summary

The Therapeutic Goods Administration is seeking feedback on proposals for a priority-review pathway and a system for designating Australian conformity assessment bodies. Both efforts promise to speed products to market and might also involve new fees for industry.


Related Content

No Delays Expected As Australian Bill On Faster Drug Approvals Goes To Parliament
Australia Accepts Three Approval Pathways, Defers Registry For High-Risk Devices
Australia to ease regulatory burden for devices and drugs





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts